Pfizer, Sanofi Find Relief As Delaware Top Court Rejects Zantac Expert Testimony - Pfizer (NYSE:PFE), Sanofi (NASDAQ:SNY)

Pfizer, Sanofi Find Relief As Delaware Top Court Rejects Zantac Expert Testimony - Pfizer (NYSE:PFE), Sanofi (NASDAQ:SNY)

The Delaware Supreme Court has overturned a lower court’s decision that allowed expert testimony supporting plaintiffs’ claims in a high-profile case alleging that Zantac, or its generic ranitidine, can cause cancer. The justices concluded that the trial court applied an incorrect legal standard when it ruled that the reliability of expert opinions should be determined by a jury rather than by the judge. Initially marketed by a forerunner of GSK…

Sanofi returns as sponsor of British Transplant Games

Sanofi is sponsoring the event for the second year in a row, which brings together 1,000 transplant recipients and live donors to compete.